Alois B. Lang
Corporate Officer/Principal en University of Bern .
Perfil
Alois B.
Lang was the founder of Kenta Biotech AG, where he held the title of Chief Scientific Officer in 2006.
Currently, he is a Professor-Immunology at the University of Bern.
Previously, he worked as the Chief Development Officer at GeNeuro SA (Switzerland).
Dr. Lang obtained his doctorate degree from the Swiss Federal Institute of Technology.
Cargos activos de Alois B. Lang
Empresas | Cargo | Inicio |
---|---|---|
University of Bern | Corporate Officer/Principal | - |
Antiguos cargos conocidos de Alois B. Lang.
Empresas | Cargo | Fin |
---|---|---|
GENEURO SA | Corporate Officer/Principal | 31/12/2018 |
Kenta Biotech AG
Kenta Biotech AG BiotechnologyHealth Technology Kenta Biotech AG engages in the research, development, production, and marketing of biotechnological and pharmaceutical products. It also specializes in the discovery and development of monoclonal antibodies for the treatment of life-threatening hospital infections. The company was founded by Alois B. Lang on February 9, 2006 and is headquartered in Zug, Switzerland. | Fundador | - |
Formación de Alois B. Lang.
Swiss Federal Institute of Technology | Doctorate Degree |
Experiencias
Funciones ocupadas
Activas
Inactivas
Empresas cotizadas
Empresas privadas
Relaciones
Relaciones de 1er grado
Empresas vinculadas al 1er grado
Hombre
Mujer
Administradores
Ejecutivos
Empresas relacionadas
Empresas cotizadas | 1 |
---|---|
GENEURO SA | Health Technology |
Empresas privadas | 1 |
---|---|
Kenta Biotech AG
Kenta Biotech AG BiotechnologyHealth Technology Kenta Biotech AG engages in the research, development, production, and marketing of biotechnological and pharmaceutical products. It also specializes in the discovery and development of monoclonal antibodies for the treatment of life-threatening hospital infections. The company was founded by Alois B. Lang on February 9, 2006 and is headquartered in Zug, Switzerland. | Health Technology |
- Bolsa de valores
- Insiders
- Alois B. Lang